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Nowadays, bacterial resistance to the different antibiotics is a major 
public health problem [1-4]. Recent outbreaks, like the one found 
in Germany for E. coli O104 [5,6] as well as the emergence of multi-
drug resistant organisms, such as gram-negative Enterobacteriaceae 
associated to the New Delhi metallo β-lactamase [7-9] evidence this 
problem [4,10-12], that not only has public health implications, but 
also at an economic and social level, threatening global safety [13,14]. 
The latest studies reported also the significant financial burden on 
health care-associated infections (HAIs) in the USA[15,16]. In the UK, 
approximately 9% of hospitalized patients acquire an infection after 
post-admission to hospital which increases the budget in the health 
care system [15,17]. 
Characterisation of the Escherichia coli strain associated with an outbreak 
of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. 
Lancet Infect Dis 11: 671-676.
Until approximately 1960, scientists produced and developed 
more, than 20 new classes of antibiotics. Since then, only two new 
classes of antibiotics have appeared [18]. The problem of resistance 
presented by bacteria is well known for approximately 20 years or 
more but pharmaceutical industry does not invest in development 
of new antibiotics [18]. This may be due to the fact that the period 
necessary for bacteria to develop resistance is becoming shorter [19], 
and consequently increases the challenges that pharmaceutical industry 
faces [20]. Instead of developing new antimicrobial agents that prove to 
be more expensive and unsuccessful [19], scientific community opt for 
another approach – modification of existing antimicrobial agents and 
further studies [19,21]. 
This could lead to the use of non-antibiotics compounds that have 
antimicrobial properties [21,22]. These molecules could act through 
a new mechanism, or may interfere with the developed resistance 
mechanism, and could revert the resistance phenotype, previously 
presented. In the last case, for example, the mechanism of action 
may be: an alteration of membrane permeability to antibiotics [22], 
inhibition of efflux pumps [23], or the inhibition of beta-lactamases, 
when the resistance mechanism is present.
In this context, it is important to know and study the resistance 
mechanisms, and also study non-antibiotics compounds as 
antimicrobial agents. 
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